ATHB17 Leader Sequence Modulates Plant Gene Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

In plant genetic engineering, achieving optimal gene expression in transgenic plants is challenging due to variables such as insertion site, regulatory sequence strength, codon usage, and presence of cryptic splice sites, often resulting in off-types and suboptimal phenotypes.

Innovation Solution

A recombinant polynucleotide comprising a genetic regulatory element, specifically the ATHB17-nt275-339 leader sequence, is operably linked to a transcribable polynucleotide, reducing transcription and translation levels, thereby improving phenotypes and avoiding off-types by acting as a leader for transcription and translation regulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If strong regulatory sequences are used to increase gene expression, then productivity is improved, but manufacturing precision deteriorates due to off-types and suboptimal phenotypes

Engineering Contradiction:
Improvegene expression levelVSAvoidphenotype consistency
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent modifies the regulatory sequence parameters by using the ATHB17-nt275-339 leader sequence, which has specific structural characteristics that modulate transcription and translation rates. This parameter change allows achieving desired expression levels while maintaining phenotype consistency and avoiding off-types.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The ATHB17-nt275-339 leader sequence acts as an intermediary element between the promoter and the coding region. It mediates the balance between achieving sufficient gene expression and maintaining precise phenotypic control, preventing both under-expression and over-expression related off-types.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If regulatory sequence strength is increased to improve gene expression, then productivity is improved, but reliability deteriorates due to variable expression patterns

Engineering Contradiction:
Improvegene expression levelVSAvoidexpression pattern stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent changes the regulatory sequence parameters by selecting the ATHB17-nt275-339 leader sequence with specific nucleotide composition and structure. This parameter optimization ensures stable and consistent gene expression patterns across different plants and tissues, improving reliability while maintaining productivity.

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If multiple variables are adjusted to optimize transgene expression, then manufacturing precision is improved, but device complexity increases

Engineering Contradiction:
Improveexpression optimizationVSAvoidconstruct complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent extracts and utilizes the specific functional elements present in the ATHB17-nt275-339 leader sequence that are responsible for optimal gene expression regulation. By focusing on this specific extracted sequence rather than adjusting multiple separate variables, the patent achieves expression optimization while minimizing construct complexity.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS10392626B1Plant regulatory elements and uses thereof
Publication Date: 2019.08.27 MONSANTO TECHNOLOGY LLC
  • US10392626B1 patent drawing
  • US10392626B1 patent drawing
  • US10392626B1 patent drawing

AI summary

The disclosure provides DNA molecules and constructs, as well as their nucleotide sequences, useful for modulating gene expression in plants. The disclosure also provides nucleic acid sequences from Arabidopsis thaliana comprising novel regulatory elements identified from the AtHB17 gene. The disclosure also provides transgenic plants, plant cells, plant parts, and seeds comprising the DNA molecules operably linked to heterologous transcribable polynucleotides are also provided, as are methods of their use.